BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
FGF21
,
Fatty acid metabolic process
,
Lung cancer
,
Hippocampus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
epoxomicin
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
heterocyclic compound binding
organic cyclic compound binding
heterocycle metabolic process
organic cyclic compound metabolic process
regulation of nitrogen compound metabolic process
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Gene expression profile in HEK293 cells treated with proteasome inhibitor epoxomicin
Explore Curated Studies Results
Literature
Most Relevant Literature
Heterologous Expression of Epoxomicin in Escherichia coli.
Synthesis and Application of a Clickable Epoxomicin-Based Probe for Proteasome Activity Analysis.
Solid-Phase Synthesis and Application of a Clickable Version of Epoxomicin for Proteasome Activity A…
Suppression of the TRIF-dependent signaling pathway of TLRs by epoxomicin.
SH-SY5Y and LUHMES cells display differential sensitivity to MPP+, tunicamycin, and epoxomicin in 2D…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ